Item 2. Properties.
4K characters. Original on sec.gov · Markdown
Item 2. Properties.
The following is a summary of Cooper's principal facilities as of October 31, 2021. We generally lease our office and operations facilities but own several manufacturing and research and development facilities, including 226,342 square feet in the United Kingdom, 164,946 square feet in Costa Rica, 63,787 square feet in Denmark, 76,778 square feet in New York and 33,630 square feet in Texas. Our lease agreements expire at various dates through the year 2045. We believe our properties are suitable and adequate for our businesses.
| Location | Approximate Square Feet | Operations | |||||||||
| AMERICAS | |||||||||||
| United States: | |||||||||||
| California | 129,540 | Executive offices; CooperVision research and development and administrative offices; CooperSurgical manufacturing and office | |||||||||
| New York | 423,175 | CooperVision manufacturing, sales / commercial offices, distribution and administrative offices; CooperSurgical manufacturing, office and distribution | |||||||||
| Connecticut | 301,962 | CooperSurgical manufacturing, sales / commercial offices, distribution, research and development and administrative offices | |||||||||
| Texas | 36,113 | CooperSurgical sales / commercial offices, manufacturing and office | |||||||||
| Puerto Rico | 527,285 | CooperVision manufacturing, research and development and distribution | |||||||||
| Costa Rica | 168,002 | CooperVision and CooperSurgical manufacturing and offices | |||||||||
| Brazil | 16,580 | CooperVision sales / commercial offices and distribution | |||||||||
| Canada | 25,154 | CooperVision sales / commercial offices and CooperSurgical office | |||||||||
| Other Americas | 114,197 | CooperVision manufacturing, sales / commercial offices and distribution; CooperSurgical sales / commercial offices and laboratory | |||||||||
| EMEA | |||||||||||
| United Kingdom | 797,647 | CooperVision manufacturing, sales / commercial offices, distribution, research and development and administrative offices; CooperSurgical sales / commercial offices, manufacturing, and genetics lab | |||||||||
| Hungary | 330,269 | CooperVision manufacturing, distribution and sales / commercial offices | |||||||||
| Belgium | 280,067 | CooperVision distribution | |||||||||
| Spain | 180,058 | CooperVision distribution, sales / commercial offices and administrative offices; CooperSurgical sales / commercial offices | |||||||||
| Denmark | 63,787 | CooperSurgical manufacturing, marketing and administrative offices | |||||||||
| Other EMEA | 286,128 | CooperVision sales / commercial offices; CooperSurgical manufacturing, sales / commercial offices and distribution | |||||||||
| ASIA PACIFIC | |||||||||||
| Japan | 87,588 | CooperVision sales / commercial, distribution and administrative offices; CooperSurgical laboratory, sales, marketing and distribution | |||||||||
| Australia | 27,005 | CooperVision sales / commercial, distribution and administrative offices; CooperSurgical sales / distribution offices | |||||||||
| Other Asia Pacific | 96,780 | CooperVision and CooperSurgical sales / commercial offices and distribution |
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Previous: Item 1B. Unresolved Staff Comments. · Next: Item 3. Legal Proceedings.
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details